Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54


Role of Nuclear Receptors in Central Nervous System Development and Associated Diseases.

Olivares AM, Moreno-Ramos OA, Haider NB.

J Exp Neurosci. 2016 May 5;9(Suppl 2):93-121. doi: 10.4137/JEN.S25480. eCollection 2015. Review.


Non-canonical functions of cell cycle cyclins and cyclin-dependent kinases.

Hydbring P, Malumbres M, Sicinski P.

Nat Rev Mol Cell Biol. 2016 May;17(5):280-92. doi: 10.1038/nrm.2016.27. Epub 2016 Apr 1.


Cyclin D1 Promotes Androgen-Dependent DNA Damage Repair in Prostate Cancer Cells.

Casimiro MC, Di Sante G, Ju X, Li Z, Chen K, Crosariol M, Yaman I, Gormley M, Meng H, Lisanti MP, Pestell RG.

Cancer Res. 2016 Jan 15;76(2):329-38. doi: 10.1158/0008-5472.CAN-15-0999. Epub 2015 Nov 18.


Epigenetically altered miR-193b targets cyclin D1 in prostate cancer.

Kaukoniemi KM, Rauhala HE, Scaravilli M, Latonen L, Annala M, Vessella RL, Nykter M, Tammela TL, Visakorpi T.

Cancer Med. 2015 Sep;4(9):1417-25. doi: 10.1002/cam4.486. Epub 2015 Jul 1.


MDC1 functionally identified as an androgen receptor co-activator participates in suppression of prostate cancer.

Wang C, Sun H, Zou R, Zhou T, Wang S, Sun S, Tong C, Luo H, Li Y, Li Z, Wang E, Chen Y, Cao L, Li F, Zhao Y.

Nucleic Acids Res. 2015 May 26;43(10):4893-908. doi: 10.1093/nar/gkv394. Epub 2015 Apr 30.


Cell-cycle-dependent regulation of androgen receptor function.

Koryakina Y, Knudsen KE, Gioeli D.

Endocr Relat Cancer. 2015 Apr;22(2):249-64. doi: 10.1530/ERC-14-0549. Epub 2015 Feb 17.


Cyclin D1 represses gluconeogenesis via inhibition of the transcriptional coactivator PGC1α.

Bhalla K, Liu WJ, Thompson K, Anders L, Devarakonda S, Dewi R, Buckley S, Hwang BJ, Polster B, Dorsey SG, Sun Y, Sicinski P, Girnun GD.

Diabetes. 2014 Oct;63(10):3266-78. doi: 10.2337/db13-1283. Epub 2014 Jun 19.


The other side of the coin: the tumor-suppressive aspect of oncogenes and the oncogenic aspect of tumor-suppressive genes, such as those along the CCND-CDK4/6-RB axis.

Lou X, Zhang J, Liu S, Xu N, Liao DJ.

Cell Cycle. 2014;13(11):1677-93. doi: 10.4161/cc.29082. Epub 2014 May 5. Review.


Androgen receptor phosphorylation: biological context and functional consequences.

Koryakina Y, Ta HQ, Gioeli D.

Endocr Relat Cancer. 2014 Aug;21(4):T131-45. doi: 10.1530/ERC-13-0472. Epub 2014 Jan 14. Review.


Identification of a cyclin D1 network in prostate cancer that antagonizes epithelial-mesenchymal restraint.

Ju X, Casimiro MC, Gormley M, Meng H, Jiao X, Katiyar S, Crosariol M, Chen K, Wang M, Quong AA, Lisanti MP, Ertel A, Pestell RG.

Cancer Res. 2014 Jan 15;74(2):508-19. doi: 10.1158/0008-5472.CAN-13-1313. Epub 2013 Nov 26.


New roles of cyclin D1.

Pestell RG.

Am J Pathol. 2013 Jul;183(1):3-9. doi: 10.1016/j.ajpath.2013.03.001. Review.


Cyclins and cell cycle control in cancer and disease.

Casimiro MC, Crosariol M, Loro E, Li Z, Pestell RG.

Genes Cancer. 2012 Nov;3(11-12):649-57. doi: 10.1177/1947601913479022.


Convergence of oncogenic and hormone receptor pathways promotes metastatic phenotypes.

Augello MA, Burd CJ, Birbe R, McNair C, Ertel A, Magee MS, Frigo DE, Wilder-Romans K, Shilkrut M, Han S, Jernigan DL, Dean JL, Fatatis A, McDonnell DP, Visakorpi T, Feng FY, Knudsen KE.

J Clin Invest. 2013 Jan;123(1):493-508. doi: 10.1172/JCI64750. Epub 2012 Dec 21.


MKP1-dependent PTH modulation of bone matrix mineralization in female mice is osteoblast maturation stage specific and involves P-ERK and P-p38 MAPKs.

Mahalingam CD, Sampathi BR, Sharma S, Datta T, Das V, Abou-Samra AB, Datta NS.

J Endocrinol. 2013 Feb 25;216(3):315-29. doi: 10.1530/JOE-12-0372. Print 2013 Mar.


miR-17-5p targets the p300/CBP-associated factor and modulates androgen receptor transcriptional activity in cultured prostate cancer cells.

Gong AY, Eischeid AN, Xiao J, Zhao J, Chen D, Wang ZY, Young CY, Chen XM.

BMC Cancer. 2012 Oct 24;12:492. doi: 10.1186/1471-2407-12-492.


ChIP sequencing of cyclin D1 reveals a transcriptional role in chromosomal instability in mice.

Casimiro MC, Crosariol M, Loro E, Ertel A, Yu Z, Dampier W, Saria EA, Papanikolaou A, Stanek TJ, Li Z, Wang C, Fortina P, Addya S, Tozeren A, Knudsen ES, Arnold A, Pestell RG.

J Clin Invest. 2012 Mar;122(3):833-43. doi: 10.1172/JCI60256. Epub 2012 Feb 6. Erratum in: J Clin Invest. 2013 May 1;123(5):2332.


Signal transduction involving the dmp1 transcription factor and its alteration in human cancer.

Sugiyama T, Frazier DP, Taneja P, Kendig RD, Morgan RL, Matise LA, Lagedrost SJ, Inoue K.

Clin Med Oncol. 2008;2:209-19. Epub 2008 Apr 1.


The AR dependent cell cycle: mechanisms and cancer relevance.

Schiewer MJ, Augello MA, Knudsen KE.

Mol Cell Endocrinol. 2012 Apr 16;352(1-2):34-45. doi: 10.1016/j.mce.2011.06.033. Epub 2011 Jul 12. Review.


Lysine methylation and functional modulation of androgen receptor by Set9 methyltransferase.

Ko S, Ahn J, Song CS, Kim S, Knapczyk-Stwora K, Chatterjee B.

Mol Endocrinol. 2011 Mar;25(3):433-44. doi: 10.1210/me.2010-0482. Epub 2011 Jan 27.

Items per page

Supplemental Content

Write to the Help Desk